"CollabRx brings to its research partners a unique set of biocomputing tools and services that help transform your genome-wide tumor data into pathways, targets and treatments."

To learn more, please contact our chief scientist, Marty Tenenbaum, at marty@collabrx.com.

CollabRx builds and operates Virtual Biotechs for foundations and patients who urgently seek cures for their diseases.

CollabRx virtual biotechs make it cost effective for small groups of researchers to conduct industrial scale R&D, focused on accelerating therapy development for rare and neglected diseases.

Virtual biotechs leverage computational and systems biology, high-throughput biology, web-based collaboration and the economies of scale afforded by sharing knowledge and resources to conduct accelerated research at a fraction of the cost of a traditional biotech.

• Potential targets and leads are generated in silico and prioritized based on all available data and knowledge; the most promising are dispatched to contractors for high throughput screening in vitro and in vivo.
• Automated workflows expedite processing, with everything tracked through real-time dashboards.
• Experimental results are used to re-prioritize the pipeline.

CollabRx virtual biotechs use web-based collaboration to enable geographically dispersed teams of researchers to function as a single lab, sharing and managing their data, knowledge, processes, resources, and research agendas.

By tightly integrating knowledge, decisions and actions, CollabRx virtual biotechs coordinate and accelerate the research cycle, focusing resources on the most promising opportunities and minimizing redundant work.

Virtual biotechs addressing different diseases can share knowledge and resources, achieving unprecedented economies of scale and acceleration through cross-learning—essential when resources are limited and life expectancies are measured in months.

Specific benefits for a research group or foundation include:

A strategic plan for how to "invest" donor giving toward research
Determining the most likely paths toward a therapy, and directing research spending toward those areas.

Tracking progress toward the cure
Receiving up-to-the-moment updates on milestones achieved as a result of prioritized research projects.

Dramatically increasing the return on investment
Making research investments go further as the researchers continually build on one another's learnings and results.

Focusing the team effort
Going after challenges bigger than any one researcher can accomplish on their own: discovering and developing therapies.


Please contact us so we can evaluate your specific needs.